Stimulating cardiac glucose oxidation lessens the severity of heart failure in aged female mice
- PMID: 38148348
- DOI: 10.1007/s00395-023-01020-2
Stimulating cardiac glucose oxidation lessens the severity of heart failure in aged female mice
Abstract
Heart failure is a prevalent disease worldwide. While it is well accepted that heart failure involves changes in myocardial energetics, what alterations that occur in fatty acid oxidation and glucose oxidation in the failing heart remains controversial. The goal of the study are to define the energy metabolic profile in heart failure induced by obesity and hypertension in aged female mice, and to attempt to lessen the severity of heart failure by stimulating myocardial glucose oxidation. 13-Month-old C57BL/6 female mice were subjected to 10 weeks of a 60% high-fat diet (HFD) with 0.5 g/L of Nω-nitro-L-arginine methyl ester (L-NAME) administered via drinking water to induce obesity and hypertension. Isolated working hearts were perfused with radiolabeled energy substrates to directly measure rates of myocardial glucose oxidation and fatty acid oxidation. Additionally, a series of mice subjected to the obesity and hypertension protocol were treated with a pyruvate dehydrogenase kinase inhibitor (PDKi) to stimulate cardiac glucose oxidation. Aged female mice subjected to the obesity and hypertension protocol had increased body weight, glucose intolerance, elevated blood pressure, cardiac hypertrophy, systolic dysfunction, and decreased survival. While fatty acid oxidation rates were not altered in the failing hearts, insulin-stimulated glucose oxidation rates were markedly impaired. PDKi treatment increased cardiac glucose oxidation in heart failure mice, which was accompanied with improved systolic function and decreased cardiac hypertrophy. The primary energy metabolic change in heart failure induced by obesity and hypertension in aged female mice is a dramatic decrease in glucose oxidation. Stimulating glucose oxidation can lessen the severity of heart failure and exert overall functional benefits.
Keywords: Cardiac energy metabolism; Cardiac glucose oxidation; Glucose oxidation; Heart failure; Pyruvate dehydrogenase; Pyruvate dehydrogenase kinase.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Similar articles
-
Mitochondrial fatty acid oxidation is the major source of cardiac adenosine triphosphate production in heart failure with preserved ejection fraction.Cardiovasc Res. 2024 Mar 30;120(4):360-371. doi: 10.1093/cvr/cvae006. Cardiovasc Res. 2024. PMID: 38193548
-
Cardiac Energy Metabolism in Heart Failure.Circ Res. 2021 May 14;128(10):1487-1513. doi: 10.1161/CIRCRESAHA.121.318241. Epub 2021 May 13. Circ Res. 2021. PMID: 33983836 Free PMC article. Review.
-
Weight loss enhances cardiac energy metabolism and function in heart failure associated with obesity.Diabetes Obes Metab. 2019 Aug;21(8):1944-1955. doi: 10.1111/dom.13762. Epub 2019 Jun 4. Diabetes Obes Metab. 2019. PMID: 31050157
-
Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.Circ Heart Fail. 2013 Sep 1;6(5):1039-48. doi: 10.1161/CIRCHEARTFAILURE.112.000228. Epub 2013 Jul 16. Circ Heart Fail. 2013. PMID: 23861485
-
Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.Biochim Biophys Acta. 2011 Jul;1813(7):1333-50. doi: 10.1016/j.bbamcr.2011.01.015. Epub 2011 Jan 20. Biochim Biophys Acta. 2011. PMID: 21256164 Review.
References
-
- Allard M, Schonekess B, Henning S, English D, Lopaschuk GD (1994) Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol 267:H742–H750. https://doi.org/10.1152/ajpheart.1994.267.2.H742 - DOI - PubMed
-
- Badolia R, Ramadurai DK, Abel ED, Ferrin P, Taleb I, Shankar TS, Krokidi AT, Navankasattusas S, McKellar SH, Yin M (2020) The role of nonglycolytic glucose metabolism in myocardial recovery upon mechanical unloading and circulatory support in chronic heart failure. Circulation 142:259–274. https://doi.org/10.1161/CIRCULATIONAHA.119.044452 - DOI - PubMed - PMC
-
- Barger PM, Kelly DP (1999) Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms. Am J Med Sci 318:36–42. https://doi.org/10.1097/00000441-199907000-00006 - DOI - PubMed
-
- Bersin RM, Wolfe C, Kwasman M, Lau D, Klinski C, Tanaka K, Khorrami P, Henderson GN, de Marco T, Chatterjee K (1994) Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate. J Am Coll Cardiol 23:1617–1624. https://doi.org/10.1016/0735-1097(94)90665-3 - DOI - PubMed
-
- Bøgh N, Hansen ES, Omann C, Lindhardt J, Nielsen PM, Stephenson RS, Laustsen C, Hjortdal VE, Agger P (2020) Increasing carbohydrate oxidation improves contractile reserves and prevents hypertrophy in porcine right heart failure. Sci Rep 10:8158. https://doi.org/10.1038/s41598-020-65098-7 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical